|15th July 2020||Pharma Ventures Pty Ltd Mayne||3,189,688||Other acquisition or disposition||$0.00|
|2nd December 2019||Garrison J. Hasara||13,500||Open or private purchase||$0.07||$945.00|
|15th January 2019||Pharma Ventures Pty Ltd Mayne||362,121||Other acquisition or disposition||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
HedgePath Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company. It discovers, develops and plans to commercialize therapeutics for patients with cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.